Results 251 to 260 of about 119,425 (295)
Some of the next articles are maybe not open access.

C1 inhibitor deficiency: management

Clinical and Experimental Dermatology, 2005
This is the second of two articles on C1 inhibitor deficiency based on a recent UK consensus document covering its diagnosis and management in adults and children. This summary focuses on the management of the disorder including prophylaxis, emergency treatment and special situations such as pregnancy and dental care.
M M, Gompels, R J, Lock
openaire   +2 more sources

C1-inhibitor autoantibodies in SLE

Lupus, 2010
The presence of anti-C1-inhibitor (anti-C1-INH) autoantibodies is a hallmark of acquired C1-inhibitor deficiency. However, only scarce data are available on their prevalence, diagnostic value, and/or significance in systemic lupus erythematosus (SLE).
T, Mészáros   +14 more
openaire   +2 more sources

Structure and Function of C1-Inhibitor

Immunology and Allergy Clinics of North America, 2006
C1-INH belongs to the family of serpins. Structural studies have yielded a clear understanding of the biochemical principle underlying the functional activities of these proteins. Although the crystal structure of C1-INH has yet to be revealed, homology modeling has provided a three-dimensional model of the serpin part of C1-INH.
Ineke G A, Wagenaar-Bos, C Erik, Hack
openaire   +2 more sources

C1 esterase inhibitor in pregnancy

Journal of Allergy and Clinical Immunology, 1992
This patient had multiple diagnoses, including lymphadenopathic mastocytosis with involvement of the spleen, liver, abdominal lymph nodes, skeleton, bone marrow, skin, and gastrointestinal tract. He was also diagnosed with acute nonlymphocytic leukemia predated by the discovery of a biclonal gammopathy.
A J, Cohen, C, Laskin, S, Tarlo
openaire   +2 more sources

Acquired C1 Inhibitor Deficiency

Immunology and Allergy Clinics of North America, 2017
Acquired angioedema due to C1-INH deficiency (C1-INH-AAE) can occur when there are acquired (not inherited) deficiencies of C1-INH. A quantitative or functional C1-INH deficiency with negative family history and low C1q is diagnostic of C1-INH-AAE. The most common conditions associated with C1-INH-AAE are autoimmunity and B-cell lymphoproliferative ...
Iris M, Otani, Aleena, Banerji
openaire   +2 more sources

Acute consumption of C1 inhibitor in a patient with acquired C1-inhibitor deficiency syndrome

Journal of Allergy and Clinical Immunology, 1991
Acquired C1-inhibitor (C1 INH) deficiency is usually found in association with an underlying disease that is believed to be responsible for increased C1 INH catabolism, ultimately leading to the development of C1 INH deficiency. We report a remarkable patient with acquired C1 INH deficiency in whom a unique progression of complement- and contact-system
B L, Zuraw, L C, Altman
openaire   +2 more sources

Biological effects of C1 inhibitor

Drug News & Perspectives, 2004
C1 inhibitor is a serine proteinase inhibitor (serpin) that regulates activation of both the complement and contact systems. Regulation of complement system activation takes place through inactivation of the classical pathway proteases, C1r and C1s, the lectin pathway protease, MASP2, and perhaps via inhibition of alternative pathway activation by ...
openaire   +2 more sources

[C1-inhibitor].

Nihon rinsho. Japanese journal of clinical medicine, 2000
Ranol Zahedi, Alvin E. Davis
openaire   +4 more sources

C1 inhibitor deficiency

Clinical and Experimental Dermatology, 2005
M, Darling, M L, Price
openaire   +2 more sources

Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1.

Biochimica et biophysica acta, 1979
1. Insoluble IgG-ovalbumin aggregates were used to bind and activate C1 from human serum. The bound C1 provided a useful reagent for studying the interaction of C1 subcomponents with C1-inhibitor. 2. C1-inhibitor bound to both subcomponents (C1r and C1s in C1 and formed stable complexes of respective apparent molecular weights 197,000 and 185,000, as ...
G J, Arlaud   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy